Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors-Reference-Cited by-同舟云学术

Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors

Published:2016-04 Issue:4 Volume:27 Page:746-747
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

van Adrichem R.C.S.,Kamp K.,Vandamme T.,Peeters M.,Feelders R.A.,de Herder W.W.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/4/746/16700178/mdv626.pdf

Reference5 articles.

1. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones;Nobels;J Clin Endocrinol Metab,1997

2. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours;Baudin;Br J Cancer,1998

3. Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours;Oberg;Endocr Relat Cancer,2011

4. Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus;Yao;J Clin Endocrinol Metab,2011

5. The ENETS guidelines: the new TNM classification system;Rindi;Tumori,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A neuroendocrine biomarker revolution from monoanalyte to multianalyte biomarkers in non-functioning gastro-entero-pancreatic neuroendocrine neoplasms;Critical Reviews in Oncology/Hematology;2024-11

2. Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients;Endocrine Journal;2024

3. Small Intestinal, Colorectal, and Appendicular Neuroendocrine Tumors;Neuroendocrine Tumours;2024

4. The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective;Current Treatment Options in Oncology;2023-11-22

5. Established and novel circulating neuroendocrine tumor biomarkers for diagnostic, predictive and prognostic use;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09